BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16890288)

  • 21. Oxidative stress levels are correlated with P15 and P16 gene promoter methylation in myelodysplastic syndrome patients.
    Gonçalves AC; Cortesão E; Oliveiros B; Alves V; Espadana AI; Rito L; Magalhães E; Pereira S; Pereira A; Costa JM; Mota-Vieira L; Sarmento-Ribeiro AB
    Clin Exp Med; 2016 Aug; 16(3):333-43. PubMed ID: 25982567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant p15 gene promoter methylation in therapy-related myelodysplastic syndrome and acute myeloid leukaemia: clinicopathological and karyotypic associations.
    Au WY; Fung A; Man C; Ma SK; Wan TS; Liang R; Kwong YL
    Br J Haematol; 2003 Mar; 120(6):1062-5. PubMed ID: 12648079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter hypermethylation analysis in myelodysplastic syndromes: diagnostic & prognostic implication.
    Solomon PR; Munirajan AK; Tsuchida N; Muthukumarasamy K; Rathinavel A; Selvam GS; Shanmugam G
    Indian J Med Res; 2008 Jan; 127(1):52-7. PubMed ID: 18316853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Methylation of P15INK4B gene in patients with myelodysplastic syndromes and demethylating effects of drugs].
    Ye XS; Liu T; Cui X; Meng WT; Xi YM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):57-9. PubMed ID: 17294728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant methylation of DNA-damage-inducible transcript 3 promoter is a common event in patients with myelodysplastic syndrome.
    Lin J; Wang YL; Qian J; Yao DM; Zhu ZH; Qian Z; Xu WR
    Leuk Res; 2010 Aug; 34(8):991-4. PubMed ID: 20116099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation profiling of myelodysplastic syndrome hematopoietic progenitor cells during in vitro lineage-specific differentiation.
    Hopfer O; Komor M; Koehler IS; Schulze M; Hoelzer D; Thiel E; Hofmann WK
    Exp Hematol; 2007 May; 35(5):712-23. PubMed ID: 17577921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Abnormality of p15(INK4b) gene and myelodysplastic syndrome].
    Wang Z; Li YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):362-5. PubMed ID: 12513775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CpG island methylator phenotype of myelodysplastic syndrome identified through genome-wide profiling of DNA methylation and gene expression.
    Zhao X; Yang F; Li S; Liu M; Ying S; Jia X; Wang X
    Br J Haematol; 2014 Jun; 165(5):649-58. PubMed ID: 24601943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p15INK4b methylation correlates with thrombocytopenia, blast percentage, and survival in myelodysplastic syndromes in a dose dependent manner: quantitation using pyrosequencing study.
    Kim M; Oh B; Kim SY; Park HK; Hwang SM; Kim TY; She CJ; Yang I; Yoon SS; Yoon JH; Lee DS
    Leuk Res; 2010 Jun; 34(6):718-22. PubMed ID: 19782398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Methylation status of ZO-1 gene in patients with myelodysplastic syndrome].
    Kang HY; Wang C; Dou LP; Qing Y; Han XP; Sun JF; Liu CH; Lu XC; Liu Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):70-3. PubMed ID: 18315903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypermethylation of the p15INK4B gene in myelodysplastic syndromes.
    Uchida T; Kinoshita T; Nagai H; Nakahara Y; Saito H; Hotta T; Murate T
    Blood; 1997 Aug; 90(4):1403-9. PubMed ID: 9269757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
    Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance of methylation status of zo-1 gene in differential diagnosis for myelodysplastic syndrome].
    Kang HY; Wang XR; Wang LL; Wang C; Cen J; Gao L; Liu Y; Li YH; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):76-80. PubMed ID: 21362226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome.
    Lin J; Yao DM; Qian J; Wang YL; Han LX; Jiang YW; Fei X; Cen JN; Chen ZX
    Leuk Res; 2008 Oct; 32(10):1541-5. PubMed ID: 18367246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome.
    Olk-Batz C; Poetsch AR; Nöllke P; Claus R; Zucknick M; Sandrock I; Witte T; Strahm B; Hasle H; Zecca M; Stary J; Bergstraesser E; De Moerloose B; Trebo M; van den Heuvel-Eibrink MM; Wojcik D; Locatelli F; Plass C; Niemeyer CM; Flotho C;
    Blood; 2011 May; 117(18):4871-80. PubMed ID: 21406719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of aberrant p73 promoter methylation in patients with myelodysplastic syndrome].
    Zhao YS; Yang R; Gu SC; Guo J; Zhang X; Wu LY; Li X; Chang CK
    Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):847-51. PubMed ID: 23384909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant hypermethylation of CTNNA1 gene is associated with higher IPSS risk in patients with myelodysplastic syndrome.
    Qian J; Chen XX; Qian W; Yang J; Wen XM; Ma JC; Deng ZQ; Qian Z; Zhang YY; Lin J
    Clin Chem Lab Med; 2014 Dec; 52(12):1859-65. PubMed ID: 25153418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of novel myeloid precursor cell line, PC-MDS, established from a bone marrow of the patient with therapy-related myelodysplastic syndrome.
    Bogdanović G; Jurisić V; Kraguljac N; Mrdjanović J; Jakimov D; Krtolica K; Krajnović M; Magić Z; Stojiljković B; Andrijević L; Srdić T; Baltić M; Popović S
    Leuk Res; 2007 Aug; 31(8):1097-1105. PubMed ID: 17350682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical Implications on ZO-1 Gene Methylation in Myelodysplastic Syndrome Progression].
    Kang HY; Wang XR; Gao L; Wang W; Li MY; Wang LL; Wang CB; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):746-9. PubMed ID: 26117030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia.
    Johan MF; Bowen DT; Frew ME; Goodeve AC; Reilly JT
    Br J Haematol; 2005 Apr; 129(1):60-5. PubMed ID: 15801956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.